BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19389397)

  • 1. Carbohydrate analysis of Acanthamoeba castellanii.
    Dudley R; Jarroll EL; Khan NA
    Exp Parasitol; 2009 Aug; 122(4):338-43. PubMed ID: 19389397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acanthamoeba castellanii: identification and distribution of actin cytoskeleton.
    González-Robles A; Castañón G; Hernández-Ramírez VI; Salazar-Villatoro L; González-Lázaro M; Omaña-Molina M; Talamás-Rohana P; Martínez-Palomo A
    Exp Parasitol; 2008 Jul; 119(3):411-7. PubMed ID: 18486940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balamuthia mandrillaris: role of galactose in encystment and identification of potential inhibitory targets.
    Siddiqui R; Jarroll EL; Khan NA
    Exp Parasitol; 2010 Sep; 126(1):22-7. PubMed ID: 19766634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms associated with Acanthamoeba castellanii (T4) phagocytosis.
    Alsam S; Sissons J; Dudley R; Khan NA
    Parasitol Res; 2005 Aug; 96(6):402-9. PubMed ID: 15940518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encystment of Acanthamoeba during incubation in multipurpose contact lens disinfectant solutions and experimental formulations.
    Kilvington S; Heaselgrave W; Lally JM; Ambrus K; Powell H
    Eye Contact Lens; 2008 May; 34(3):133-9. PubMed ID: 18463477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different environmental conditions on the encystation of Acanthamoeba castellanii belonging to the T4 genotype.
    Aqeel Y; Siddiqui R; Iftikhar H; Khan NA
    Exp Parasitol; 2013 Sep; 135(1):30-5. PubMed ID: 23769934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural study of encystation and excystation in Acanthamoeba castellanii.
    Chávez-Munguía B; Omaña-Molina M; González-Lázaro M; González-Robles A; Bonilla P; Martínez-Palomo A
    J Eukaryot Microbiol; 2005; 52(2):153-8. PubMed ID: 15817120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.
    Debnath A; Tunac JB; Silva-Olivares A; Galindo-Gómez S; Shibayama M; McKerrow JH
    Antimicrob Agents Chemother; 2014; 58(3):1523-8. PubMed ID: 24366747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis.
    Dudley R; Alsam S; Khan NA
    Appl Microbiol Biotechnol; 2007 May; 75(1):133-40. PubMed ID: 17225099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of alpha-helical and beta-hairpin antimicrobial peptides against Acanthamoeba castellanii.
    Sacramento RS; Martins RM; Miranda A; Dobroff AS; Daffre S; Foronda AS; De Freitas D; Schenkman S
    Parasitology; 2009 Jul; 136(8):813-21. PubMed ID: 19490729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of Acanthamoeba castellanii to produce intraocular infections.
    Clarke DW; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2472-8. PubMed ID: 15980238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii.
    Anwar A; Abdalla SAO; Aslam Z; Shah MR; Siddiqui R; Khan NA
    Parasitol Res; 2019 Jul; 118(7):2295-2304. PubMed ID: 31093751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of Acanthamoeba castellanii cytopathic effect.
    Taylor WM; Pidherney MS; Alizadeh H; Niederkorn JY
    J Parasitol; 1995 Aug; 81(4):603-9. PubMed ID: 7623204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of an ectophosphatase activity involved in Acanthamoeba castellanii adhesion to host cells.
    Carvalho-Kelly LF; Freitas-Mesquita AL; Ferreira Pralon C; de Souza-Maciel E; Meyer-Fernandes JR
    Eur J Protistol; 2023 Oct; 91():126026. PubMed ID: 37871554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Acanthamoeba species to complement lysis.
    Toney DM; Marciano-Cabral F
    J Parasitol; 1998 Apr; 84(2):338-44. PubMed ID: 9576508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Value of Cellulose Synthesis Inhibitors Combined With PHMB in the Treatment of Acanthamoeba Keratitis.
    Moon EK; Hong Y; Chung DI; Goo YK; Kong HH
    Cornea; 2015 Dec; 34(12):1593-8. PubMed ID: 26426333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype.
    Siddiqui R; Lakhundi S; Iqbal J; Khan NA
    Exp Parasitol; 2016 Sep; 168():45-50. PubMed ID: 27381503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomic force microscopic imaging of Acanthamoeba castellanii and Balamuthia mandrillaris trophozoites and cysts.
    Aqeel Y; Siddiqui R; Ateeq M; Raza Shah M; Kulsoom H; Khan NA
    J Eukaryot Microbiol; 2015; 62(1):85-94. PubMed ID: 25041405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The most abundant cyst wall proteins of Acanthamoeba castellanii are lectins that bind cellulose and localize to distinct structures in developing and mature cyst walls.
    Magistrado-Coxen P; Aqeel Y; Lopez A; Haserick JR; Urbanowicz BR; Costello CE; Samuelson J
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007352. PubMed ID: 31095564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein.
    Garate M; Marchant J; Cubillos I; Cao Z; Khan NA; Panjwani N
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1056-62. PubMed ID: 16505041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.